H&T Presspart acquires global rights to Hovione's dry powder inhaler

H&T Presspart announced the acquisition of global rights to a capsule-based dry powder inhaler developed by Hovione, which will be manufactured and commercialized as PowdAir Plus. The companies will continue to collaborate.

“This is a strategically significant partnership for H&T Presspart and underlines our commitment to forging alliances that accelerate the development, global scale-up and commercialization of novel drug delivery solutions for respiratory patients.”oindpnews.com

• 1 source
• oindpnews.comH&T Presspart announces partnership with Hovione and launches the PowdAir Plus DPI – OINDPnewsApr 1, 2017

Summarized from public sources; check the original articles before acting on it.